Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.81 |
| ▸ | PPARG | P37231 | 7/20 | 0.81 |
| ▸ | PPARD | Q03181 | 7/20 | 0.81 |
| ▸ | PPARA | Q07869 | 7/20 | 0.81 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.81 |
| ▸ | TSHR | P16473 | 4/20 | 0.81 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.81 |
| ▸ | FABP4 | P15090 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.81 |
| ▸ | TLR2 | O60603 | 2/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.81 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.81 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.81 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.81 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | ESR1 | P03372 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL10489552 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL28534845 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL1682245 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL6559646 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL9748587 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL25269213 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL11054069 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL15603224 | 1.00 | GPR84 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL1682224 | 0.98 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL28753435 | 0.98 | GPR84 (0.77) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110876756-A | Ointment for treating onychomycosis | 罗香英 | 2020-03-13 | — | — | CN | claimed |
| CN-108635280-A | Repair face mask cream | 深圳市还原美美容管理顾问有限公司 | 2018-10-12 | — | — | CN | claimed |
| CN-107913199-A | A kind of volcano mud acne-dispelling face pack | 曾俊平 | 2018-04-17 | — | — | CN | claimed |
| CN-101125155-B | Application of erigeron breviscapus methanol extracts in skin-whitening and speckle eliminating prevention | UNIV SICHUAN | 2010-11-10 | — | — | CN | claimed |
| CN-101181638-A | Female surface coating contraceptive | DINGCHAO CHENG (CN) | 2008-05-21 | — | — | CN | claimed |
| CN-101129305-A | Water-soluble fibroin face pack for beauty treatment | UNIV ZHEJIANG (CN) | 2008-02-27 | — | — | CN | claimed |
| EP-4380572-B1 | FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL | ONYCHOPHARM GMBH (DE) | 2025-10-01 | — | — | EP | disclosed |
| CN-115819998-B | Modified cerium oxide nano-sheet powder and preparation method thereof | 上海联锴新材料有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-115819998-A | Modified cerium dioxide nanosheet powder and preparation method thereof | 上海联锴新材料有限公司 | 2023-03-21 | — | — | CN | disclosed |
| EP-4129292-A1 | FORMULATION FOR SUBSTITUTED 2-AMINOTHIAZOLES IN THE TREATMENT OF FUNGAL AND FUNGAL-BACTERIAL INFECTIONS OF THE NAIL | OnychoPharm GmbH (DE) | 2023-02-08 | — | — | EP | disclosed |
| EP-3878840-A1 | CRYSTALLINE FORMS OF SALTS OF N1,N12-DI (ALL-TRANS-RETINOYL)SPERMINE, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS THEREOF | University of Patras (GR) | 2021-09-15 | — | — | EP | disclosed |
| CN-112438900-A | Composition for oxidative hair dyeing or composition for bleaching and bleaching hair | 朋友株式会社 | 2021-03-05 | — | — | CN | disclosed |
| CN-110876756-A | Ointment for treating onychomycosis | 罗香英 | 2020-03-13 | — | — | CN | disclosed |
| CN-1712022-A | Process and compositions for the protection and/or the treatment of dry and/or sensitive skin | OREAL (FR) | 2005-12-28 | — | — | CN | disclosed |
| EP-1397108-A1 | MICROEMULSION FACIAL WASHES COMPRISING SPECIFIC OILS | Unilever Plc (GB) | 2004-03-17 | — | — | EP | disclosed |
| US-20030095990-A1 | Microemulsion facial washes comprising specific oils | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-05-22 | — | — | US | disclosed |
| WO-2002102327-A1 | MICROEMULSION FACIAL WASHES COMPRISING SPECIFIC OILS | UNILEVER PLC (GB) | 2002-12-27 | — | — | WO | disclosed |
| US-5427684-A | Biocompatibility; damage to blood cells minimized | AKZO NV (NL) | 1995-06-27 | — | — | US | disclosed |
| US-5273898-A | Thermally stable and positionally non-specific lipase isolated from Candida | NORO NORDISK A/S (DK) | 1993-12-28 | — | — | US | disclosed |
| EP-0024176-B1 | COMPOSITION FOR INHIBITING AXILLARY ODOUR | UNILEVER PLC (GB) | 1983-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095990-A1 | Microemulsion facial washes comprising specific oils | MGLL, SQLE, LIPA | GPR84 13/4885PPARG 204/4885PPARD 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.